Jamieson Labs sold to US private equity firm

By Hank Schultz

- Last updated on GMT

Related tags: Canada, United states, Investment

Jamieson Labs sold to US private equity firm
Jamieson’s Laboratories, Ltd, Canada’s leading dietary supplement manufacturer, has entered into an agreement to sell the company to CCMP Capitol Advisors for a reported $300 million.

Eric Margolies will remain chairman of the Jamieson board and will act as a consultant for the new company. Vic Neufel, Jamieson’s current CEO, will stay on, too.

"I've been leading Jamieson for 41 years. Today, one in three Canadians take Jamieson supplements making it this country's number one vitamin brand.  Jamieson will benefit from new infusions of capital and top line management to continue its growth, including expansion into the United States and internationally, to achieve our goal of becoming a world market leader,”​ Margolies said in a statement.

Established in 1922, Jamieson Laboratories is Canada's largest manufacturer and distributor of advanced natural-health products and a world-leading innovator in the development of proprietary supplement formulas. Jamieson products are made at the company's state-of-the-art laboratories in Windsor, Ontario. With corporate offices in Toronto, Jamieson exports products to more than 50 countries.

CCMP Capital Advisors, LLC  specializes in middle market buyouts and growth equity investments of $100 million to $500 million in the U.S. and Europe.  CCMP invests in four primary industries: consumer, industrial, energy and healthcare. 

Related news

Related products

show more

Whitepaper: Optimizing immunity with vitamin D

Whitepaper: Optimizing immunity with vitamin D

DSM Nutritional Products | 16-Jun-2022 | Technical / White Paper

With vitamin D science evolving rapidly since the COVID-19 pandemic, our new whitepaper breaks down the latest research on the role of vitamin D in supporting...

Related suppliers

Follow us

Products

View more

Webinars